These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12390952)

  • 1. Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma.
    O'Brien KD; Shavelle DM; Caulfield MT; McDonald TO; Olin-Lewis K; Otto CM; Probstfield JL
    Circulation; 2002 Oct; 106(17):2224-30. PubMed ID: 12390952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of local angiotensin II-producing systems in stenotic aortic valves.
    Helske S; Lindstedt KA; Laine M; Mäyränpää M; Werkkala K; Lommi J; Turto H; Kupari M; Kovanen PT
    J Am Coll Cardiol; 2004 Nov; 44(9):1859-66. PubMed ID: 15519020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis.
    O'Brien KD; Reichenbach DD; Marcovina SM; Kuusisto J; Alpers CE; Otto CM
    Arterioscler Thromb Vasc Biol; 1996 Apr; 16(4):523-32. PubMed ID: 8624774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (Pro)renin receptors and angiotensin converting enzyme 2/angiotensin-(1-7)/Mas receptor axis in human aortic valve stenosis.
    Peltonen T; Näpänkangas J; Ohtonen P; Aro J; Peltonen J; Soini Y; Juvonen T; Satta J; Ruskoaho H; Taskinen P
    Atherosclerosis; 2011 May; 216(1):35-43. PubMed ID: 21316680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice.
    de Nigris F; D'Armiento FP; Somma P; Casini A; Andreini I; Sarlo F; Mansueto G; De Rosa G; Bonaduce D; Condorelli M; Napoli C
    Int J Cardiol; 2001 Dec; 81(2-3):107-15; discusssion 115-6. PubMed ID: 11744122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis.
    Côté C; Pibarot P; Després JP; Mohty D; Cartier A; Arsenault BJ; Couture C; Mathieu P
    Heart; 2008 Sep; 94(9):1175-80. PubMed ID: 17932090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidized low-density lipoprotein, angiotensin II and increased waist cirumference are associated with valve inflammation in prehypertensive patients with aortic stenosis.
    Côté N; Pibarot P; Pépin A; Fournier D; Audet A; Arsenault B; Couture C; Poirier P; Després JP; Mathieu P
    Int J Cardiol; 2010 Dec; 145(3):444-9. PubMed ID: 19525020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein lipase in aortic valve stenosis is associated with lipid retention and remodelling.
    Mahmut A; Boulanger MC; Fournier D; Couture C; Trahan S; Pagé S; Arsenault B; Després JP; Pibarot P; Mathieu P
    Eur J Clin Invest; 2013 Jun; 43(6):570-8. PubMed ID: 23550604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymatically Modified Low-Density Lipoprotein Is Present in All Stages of Aortic Valve Sclerosis: Implications for Pathogenesis of the Disease.
    Twardowski L; Cheng F; Michaelsen J; Winter S; Hofmann U; Schaeffeler E; Müller S; Sonnenberg M; Steuer K; Ott G; Schwab M; Franke UF; Torzewski M
    J Am Heart Assoc; 2015 Oct; 4(10):e002156. PubMed ID: 26475297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contributions of leukocyte angiotensin-converting enzyme to development of atherosclerosis.
    Chen X; Lu H; Zhao M; Tashiro K; Cassis LA; Daugherty A
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2075-80. PubMed ID: 23846498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves.
    Olsson M; Thyberg J; Nilsson J
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1218-22. PubMed ID: 10323772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies.
    Otto CM; Kuusisto J; Reichenbach DD; Gown AM; O'Brien KD
    Circulation; 1994 Aug; 90(2):844-53. PubMed ID: 7519131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease.
    Diet F; Pratt RE; Berry GJ; Momose N; Gibbons GH; Dzau VJ
    Circulation; 1996 Dec; 94(11):2756-67. PubMed ID: 8941100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability.
    Schieffer B; Schieffer E; Hilfiker-Kleiner D; Hilfiker A; Kovanen PT; Kaartinen M; Nussberger J; Harringer W; Drexler H
    Circulation; 2000 Mar; 101(12):1372-8. PubMed ID: 10736279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice.
    Hayek T; Attias J; Coleman R; Brodsky S; Smith J; Breslow JL; Keidar S
    Cardiovasc Res; 1999 Dec; 44(3):579-87. PubMed ID: 10690290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
    Keidar S; Kaplan M; Pavlotzky E; Coleman R; Hayek T; Hamoud S; Aviram M
    Circulation; 2004 May; 109(18):2213-20. PubMed ID: 15123520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment with statins and angiotensin-converting enzyme inhibitors in degenerative aortic stenosis--an up-date].
    Moldovanu CM; Pandele GI; Ambăruş V; Ionescu S
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):964-74. PubMed ID: 20191861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aortic valve stenosis: an active atheroinflammatory process.
    Helske S; Kupari M; Lindstedt KA; Kovanen PT
    Curr Opin Lipidol; 2007 Oct; 18(5):483-91. PubMed ID: 17885417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of oxidized LDL in human semilunar valves correlates with coronary atherosclerosis.
    Mehrabi MR; Sinzinger H; Ekmekcioglu C; Tamaddon F; Plesch K; Glogar HD; Maurer G; Stefenelli T; Lang IM
    Cardiovasc Res; 2000 Mar; 45(4):874-82. PubMed ID: 10728413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified lipoprotein-derived lipid particles accumulate in human stenotic aortic valves.
    Lehti S; Käkelä R; Hörkkö S; Kummu O; Helske-Suihko S; Kupari M; Werkkala K; Kovanen PT; Oörni K
    PLoS One; 2013; 8(6):e65810. PubMed ID: 23762432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.